A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

Clinical trial NCT05543616 · COMPLETED

Trial details

NCT number: NCT05543616
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Virus Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19

Start date: 2022-09-23
Primary completion: 2026-07-10
Enrollment: 4338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.